Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Reunion Neuroscience Inc T.REUN

Reunion Neuroscience Inc. is engaged in the psychedelic drug development company that provides therapeutic solutions for mental health conditions by developing serotonin receptor agonist compounds. The Company is developing the advancement of synthetic molecules targeting serotonin 5HT2A receptors. The Company’s products include RE104 and RE200. The Company’s lead asset, RE-104, which is a... see more

Bullboard (TSX:REUN)

View:
Post by Idvhmz123on May 11, 2021 9:01am

Psychedelic News

ORIGINAL: Havn Life Develops New Method for Rapid Psilocybin Testing 2021-05-11 08:03 ET - News Release Havn Life has completed its analytical work under its Health Canada Section 56 exemption ...more  
Post by rednipon May 09, 2021 8:49pm

Some may find this article of interest

https://www.nytimes.com/2021/05/09/health/psychedelics-mdma-psilocybin-molly-mental-health.html
Post by BryceCanadaon May 01, 2021 10:22am

Great watch for FTRP longs!

https://youtu.be/47XFv8AkGNs
Post by BryceCanadaon Apr 24, 2021 9:08am

Deep dive on FTRP

https://youtu.be/47XFv8AkGNs
Post by BryceCanadaon Apr 17, 2021 11:44am

Excellent FTRP YT Analysis

https://youtu.be/47XFv8AkGNs
Post by BryceCanadaon Apr 10, 2021 11:54am

Excellent YT analysis

https://youtu.be/47XFv8AkGNs
Post by BryceCanadaon Apr 05, 2021 4:32pm

Great YT Analysis on FTRP!

https://youtu.be/47XFv8AkGNs
Post by Bigguyon Mar 25, 2021 11:48am

Mushrooms for everyone!

https://www.thegrowthop.com/life/chelsea-handler-takes-mushrooms-before-appearance-on-the-tonight-show-with-jimmy-fallon
Post by evilballson Feb 28, 2021 7:49pm

$82M Bought Deal

Seems like I chose correct.   This stock is going top go up in valuation simialr to Mind Med or Compass.
Post by evilballson Feb 22, 2021 10:48pm

$8 level seems to have been attained

I have a firm beleif this is a billion dollar company this year.  The only area where they are receiving any type of poor marks is their app.  A minimum 20 treatment centers within the year ...more  
Post by evilballson Feb 16, 2021 11:21pm

MD & A says it all...

20 to 30 clinics opend up by this time next year.  I have heard average revenue once fully operational in excess of $1M per year Also have synthetic psilocybin that lasts half the duration ...more  
Post by evilballson Feb 12, 2021 2:38am

Some coverage

Beat the Market Stock Picks | Seeking market alpha with undervalued high growth opportunities… Hopefully Field Trip Health isn't a small cap one day.  
Post by evilballson Feb 12, 2021 2:25am

Niche in the portfolio

When it comes to this subsector there was not a lot to chose from who distinguished themselves in this category I think NovaMind was the other company.  The fact they have an international ...more  
Comment by evilballson Feb 12, 2021 2:03am

RE:RE:Fieldtrip

The warrants.  Someone needs to buy the warrants.  I know they haven't been listed long but geez... stock closes at $2.40 in the money but the warrants close at $1.80...  Should be  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities